메뉴 건너뛰기
Expert Review of Anticancer Therapy
Volumn 1, Issue 1, 2001, Pages 111-115
New chemoradiotherapy combinations in head and neck cancer
Author keywords

5 Fluorouracil; Chemoradiotherapy; Cisplatin; Gemcitabine; Head and neck squamous cell cancer; Irinotecan; Taxanes
Indexed keywords

AMIFOSTINE; BLEOMYCIN; CANCER VACCINE; CARBOPLATIN; CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUOROURACIL; GEMCITABINE; HYDROXYUREA; IRINOTECAN; METHOTREXATE; PACLITAXEL; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN P16; PROTEIN P53; TAXUS BREVIFOLIA EXTRACT;
EID: 0035558038     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.1.1.111     Document Type: Review
Times cited : (3)
References (23)
  • 3
    • 0034681783 scopus 로고    scopus 로고
    • Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analysis of updated individual data
    • (2000) Lancet , vol.355 , pp. 949-955
    • Pignon, J.P.1    Bourthis, J.2    Domenge, C.3
  • 4
    • 0029868441 scopus 로고    scopus 로고
    • Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials
    • (1996) J. Clin. Oncol , vol.14 , Issue.3 , pp. 838-847
    • El-Sayed, S.1    Nelson, N.2
  • 6
    • 85037024558 scopus 로고    scopus 로고
    • Pilot trial of concurrent chemotherapy with paclitaxel and conventional fractionated irradiation in advanced unresectable squamous cell carcinoma
    • Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology. New Orleans, USA, Abstract
    • (2000) , pp. 1694
    • Feher, O.1    Martins, S.J.2    Lima, C.A.3
  • 7
    • 0005957491 scopus 로고    scopus 로고
    • Concurrent radiotherapy and paclitaxel twice a week as radiosensitizer in stage III-IV Head and Neck carcinoma
    • Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology. New Orleans, USA, Abstract
    • (2000) , pp. 1670
    • Bouillet, T.1    Morere, J.2    Despreaux, D.3
  • 9
    • 0031475070 scopus 로고    scopus 로고
    • A Phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma
    • (1997) Semin. Oncol , vol.24 , Issue.SUPPL. 19 , pp. 51-56
    • Steinberg, L.1    Hassn, M.2    Olmsted, L.3
  • 10
    • 85037011093 scopus 로고    scopus 로고
    • A Phase I/II trial of accelerated radiotherapy plus concurrent 96-hour Paclitaxel infusion for unresectables squamous cell carcinoma of the head and neck
    • Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology. New Orleans, USA, Abstract
    • (2000) , pp. 1676
    • Doyle, T.1    Devine, P.2    Rosenthal, D.I.3
  • 12
    • 85037014733 scopus 로고    scopus 로고
    • Phase II study of weekly carboplatin and paclitaxel concurrent with radiation therapy in patiens with locally advanced, inoperable squamous cell carcinoma of the head and neck
    • Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology. New Orleans, USA, Abstract
    • (2000) , pp. 1667
    • Bahri, S.1    Agarwala, S.S.2    Cano, E.3
  • 14
    • 0033744649 scopus 로고    scopus 로고
    • A Phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granuloyte colony stimulating factor support for patients with poor prognosis head and neck cancer
    • (2000) Ann. Oncol , vol.11 , pp. 721-728
    • Brockstein, B.1    Haraf, D.J.2    Stenson, K.3
  • 17
    • 0013326599 scopus 로고    scopus 로고
    • Alternating chemo-radiation with docetaxel (D)/cisplatin (C) and involved field radiotherapy for recurrent, inoperable and previously irradiated head & neck cancer
    • Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology. New Orleans, USA, Abstract
    • (2000) , pp. 1649
    • Budach, W.1    Hehr, T.2    Belka, C.3
  • 18
    • 85037011893 scopus 로고    scopus 로고
    • Phase I study of irinotecan, 5-FU and hydroxyurea with radiation in recurrent or advanced head and neck cancer
    • Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology. New Orleans, USA, Abstract
    • (2000) , pp. 1650
    • Humerickhouse, R.A.1    Haraf, D.2    Stenson, B.3
  • 19
    • 85037014599 scopus 로고    scopus 로고
    • Phase I trial of radiation concurrent with low-dose gemcitabine for head and neck cancer: High mucosal and pharyngeal toxicity
    • Proceedings of the 33th Annual Meeting of American Society of Clinical Oncology. Denver, USA, Abstract
    • (1997) , pp. 1377
    • Eisbruch, A.1    Shewach, D.S.2    Urba, S.3
  • 20
    • 85037014109 scopus 로고    scopus 로고
    • Radiation concurrent with low dose gemcitabine for head and neck cancer: Interim results of a Phase I study
    • Proceedings of the 34th Annual Meeting of American Society of Clinical Oncology. Los Angeles, USA, Abstract
    • (1998) , pp. 1563
    • Eisbruch, A.1    Shewach, D.S.2    Bradford, C.R.3
  • 21
    • 0000109474 scopus 로고    scopus 로고
    • Phase I study of gemcitabine combined with radiotherapy with or without amifostine in patients with locally advanced head and neck cancer
    • Proceedings of the 36th Annual Meeting of American Society of Clinical Oncology, New Orleans, USA, Abstract
    • (2000) , pp. 1674
    • Jaremtchuk, V.1    Zarba, J.J.2    Keropian, M.3
  • 22
    • 85037006138 scopus 로고    scopus 로고
    • Phase I study of gemcitabine, 5-FU and paclitaxel with RT in recurrent or advanced head and neck cancer
    • Proceedings of the 35th Annual Meeting of American Society of Clinical Oncology. Atlanta, USA, Abstract
    • (1999) , pp. 1531
    • Humerickhouse, R.A.1    Haraf, D.2    Brockstein3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.